RESUMO
In order to evaluate the efficacy of interferon alpha (IFNa) in mixed cryoglobulinemia (MC), a prospective multicenter clinical trial was conduced in April 1992. It consisted of treating 20 clinically symptomatic MC patients with IFNa for 26 weeks. Hepatitis C virus (HCV) infection was detected in 16 patients. A complete or partial clinical remission was obtained in 12 patients (60%). Eleven of these 12 responders (91.6%) experienced a clinical relapse less than 12 months after the end of therapy. Side effects were noted in 10 patients (50%). It was concluded that subcutaneously administered IFNa does not provide long-term remission.
Assuntos
Antivirais/uso terapêutico , Crioglobulinemia/terapia , Interferon Tipo I/uso terapêutico , Corticosteroides/uso terapêutico , Idoso , Idoso de 80 Anos ou mais , Antivirais/administração & dosagem , Quimioterapia Adjuvante , Crioglobulinemia/complicações , Feminino , Hepatite C/complicações , Hepatite C/terapia , Humanos , Injeções Subcutâneas , Interferon Tipo I/administração & dosagem , Masculino , Pessoa de Meia-Idade , Troca Plasmática , Estudos Prospectivos , Proteínas Recombinantes , RecidivaRESUMO
We describe a patient with chronic urticaria in association with monoclonal IgM gammopathy (Schnitzler's syndrome). Seven years after the onset of the cutaneous lesions sensorimotor neuropathy developed. Myelin-associated glycoprotein was detected in the patient's serum. High doses of corticosteroids improved the skin condition but failed to prevent the neuropathy. Six months of treatment with immunoglobulins was without benefit.
Assuntos
Doenças Desmielinizantes/complicações , Hipergamaglobulinemia/patologia , Imunoglobulina M , Cadeias kappa de Imunoglobulina , Proteínas da Mielina , Doenças do Sistema Nervoso Periférico/complicações , Urticária/patologia , Idoso , Humanos , Hipergamaglobulinemia/complicações , Masculino , Glicoproteína Associada a Mielina , Síndrome , Urticária/complicaçõesRESUMO
Studying the prognostic value of serum interleukin-6 (IL-6) levels in multiple myeloma, we observed important daily variations in some patients. Therefore a unique serum IL-6 measurement should be interpreted with caution and requires confirmation by multiple determinations performed over a period of several days.
Assuntos
Ritmo Circadiano/fisiologia , Interleucina-6/sangue , Mieloma Múltiplo/sangue , Bioensaio , Biomarcadores Tumorais/sangue , HumanosRESUMO
OBJECTIVE: Antiphospholipid antibodies (aPL) are noted with increased frequency in patients with systemic lupus erythematosus (SLE). The main manifestations found to be associated with aPL are arterial and venous thrombotic events, thrombocytopenia, and recurrent pregnancy loss. This study is an attempt to define the incidence of aPL in patients with childhood-onset SLE and in their relatives and to correlate their presence with clinical manifestations, and especially, to evaluate the risk of thrombosis in aPL-positive subjects. METHODOLOGY: We studied 37 unrelated patients and 107 of their first-degree relatives. VDRL, IgG and IgM anticardiolipin, and IgG antiphosphatidylethanolamine antibodies were studied in all probands during periods of clinical remission and in first-degree relatives at the time of interview. Lupus anticoagulant had only been studied in probands during an SLE flare-up. RESULTS: Thirty-eight percent of probands and 19% of relatives were positive for at least one aPL, with little overlap between the different aPL studied. -No aPL-negative proband developed thrombosis. Two of the aPL-positive probands had thrombotic events before testing, and a third one showed thrombosis after testing. Only two probands had high levels of IgG aCL and showed thrombosis. The occurrence of aPL positivity in relatives was not always related to its presence in probands. None of the aPL-positive relatives had had thrombosis, but recurrent fetal loss was noted in one aPL-positive mother with SLE. Although there was a high frequency of SLE, SLE-like disease, auto-immune disorders or positive serological findings for lupus in first-degree relatives, many of these relatives did not test positive for aPL. CONCLUSION: The high levels of IgG aCL may be considered a risk factor for thrombosis. Findings in relatives suggest a multifactorial origin for autoimmune disease and antibody production.
Assuntos
Anticorpos Antifosfolipídeos/análise , Lúpus Eritematoso Sistêmico/imunologia , Aborto Habitual/imunologia , Adolescente , Idade de Início , Formação de Anticorpos/genética , Doenças Autoimunes/genética , Criança , Feminino , Humanos , Imunoglobulina G/análise , Imunoglobulina M/análise , Masculino , Gravidez , Trombocitopenia/imunologia , Tromboflebite/imunologiaRESUMO
We determined the specificity and sequence of immunoglobulin molecules synthesized by monoclonal B cells from a patient with chronic lymphocytic leukaemia (CLL) who presented with a number of clinical and biological autoimmune symptoms. Heterohybrids obtained by fusion of CLL cells with the mouse X63-Ag 8.653 myeloma produced IgM lambda MoAbs directed to the cardiolipin/beta 2 glycoprotein I (beta 2GPI) complex and ssDNA. They were devoid of polyreactivity. Nucleotide sequence analysis of the variable domain of the mu chain indicated the utilization of the VH4 71.2 gene or one allotypic variant, DXP4 and JH3 segments. The lambda light chain used the single gene from the V lambda 8 subfamily, J lambda 3 and C lambda 3 genes. The VH gene displayed 11 nucleotide changes in comparison with its putative germline counterpart. However, these nucleotide changes correspond to variations observed in other published VH4 sequences, suggesting gene polymorphism rather than somatic mutation. DXP4 and JH3 were also in germline configuration. The VL gene exhibited a single replacement mutation in CDR1. These data suggest that the monoclonal CLL B cells in this patient retained VH and VL genes in germline configuration although they secreted a pathogenic anti-cardiolipin antibody associated with clinical symptoms, vasculitis and thrombosis, which may be provoked by antibodies to the phospholipid/beta 2GPI complex.
Assuntos
Anticorpos Anticardiolipina/biossíntese , Anticorpos Monoclonais/biossíntese , Glicoproteínas/imunologia , Leucemia Linfocítica Crônica de Células B/imunologia , Sequência de Aminoácidos , Anticorpos Anticardiolipina/genética , Anticorpos Antinucleares/biossíntese , Anticorpos Antinucleares/genética , Anticorpos Monoclonais/genética , Sequência de Bases , Cardiolipinas/imunologia , Clonagem Molecular , DNA Complementar/genética , DNA de Cadeia Simples/imunologia , Genes de Imunoglobulinas , Humanos , Leucemia Linfocítica Crônica de Células B/genética , Masculino , Pessoa de Meia-Idade , Dados de Sequência Molecular , Alinhamento de Sequência , beta 2-Glicoproteína IRESUMO
OBJECTIVE: To gain insight into the genetic origin of human antilamin autoantibodies, we determined the nucleotide sequence of the light and heavy chain variable region (VL and VH) domains of 5 IgM antibodies directed to lamin B. These antibodies represent a distinct subset of antinuclear antibodies, and their presence is associated with a particular lupus-like syndrome. METHODS: We derived and cloned lymphoblastoid cell lines from peripheral blood B cells of 3 patients, selected anti-lamin B-producing subclones, and sequenced the messenger RNA coding for Ig heavy and light chains. RESULTS: We isolated 2 subclones (1 IgM kappa, 1 IgM lambda) from one patient (FUR) and 2 subclones (both IgM lambda) from another (HER). In contrast, all 8 lines derived from B cells isolated from the third patient (BEN) synthesized identical anti-lamin B IgM kappa antibodies: All VL and VH domains from these 5 IgM were encoded by different VL or VH genes. DH regions were all different, and there was no restriction in the use of JL or JH segments. Analysis of the nucleotide sequence of the VL domains allowed the identification of the putative germinal gene in 3 instances (V kappa IV, Humkv325, and V lambda III.1); the overall ratios of replacement:silent mutations (R:S) were 6.5 and 1.2 in the complementarity-determining regions (CDRs) and framework regions (FRs), respectively. The 2 other lambda sequences belonged to the V lambda III family. With regard to VH domains, 3 of 5 derived from previously identified germline genes (VHIV 4.19, VHIV 4.22, and VHIII 9.1); the overall R:S ratio for these genes was 8 and 1.5 in CDRs and FRs, respectively. CONCLUSION: Taken together, these data provide evidence that the repertoire of human antilamin autoantibodies is not restricted and that the antigen (or another kind of selective pressure) plays a role in the generation of autoantibodies to lamin B. This hypothesis is in accordance with the reactivity of these antibodies to discrete epitopes of lamin B.
Assuntos
Antígenos/imunologia , Autoanticorpos/imunologia , Imunoglobulina M/genética , Região Variável de Imunoglobulina/genética , Proteínas Nucleares/imunologia , Sequência de Bases , Humanos , Cadeias Pesadas de Imunoglobulinas/genética , Cadeias Leves de Imunoglobulina/genética , Cadeias mu de Imunoglobulina/genética , Lamina Tipo B , Laminas , Linfócitos/metabolismo , Dados de Sequência Molecular , Proteínas Nucleares/metabolismo , Sondas de Oligonucleotídeos/genética , Células-Tronco/metabolismoRESUMO
Lupoid sclerosis is a rare syndrome associating clinical symptoms of multiple sclerosis (MS), positive false tests for syphilis and positive tests for antinuclear and anticardiolipin antibodies. In a patient with lupoid sclerosis, antimyelin antibodies were detected by indirect immunofluorescence on human sciatic nerve sections. These antibodies were not found in the serum of control patients with MS nor in sera of patients with antiphospholipid autoantibodies and focal ischemic neurologic disease. The presence of such antimyelin antibodies may contribute to the underlying physiopathological mechanism of this syndrome.
Assuntos
Anticorpos Antifosfolipídeos/análise , Anticorpos/análise , Lúpus Eritematoso Sistêmico/complicações , Esclerose Múltipla/complicações , Bainha de Mielina/imunologia , Adulto , Anticorpos Anticardiolipina/análise , Imunofluorescência , Humanos , Lúpus Eritematoso Sistêmico/imunologia , Masculino , Esclerose Múltipla/imunologia , Nervo Isquiático/imunologia , SíndromeRESUMO
Using immunofluorescence and immunoblotting techniques, we have identified monoclonal IgM lambda from two patients that are specific for lamins A and C and lamin B, respectively. Lamins A, B, and C are peripheral membrane proteins of the nuclear envelope with structural similarities to cytoplasmic intermediate filament proteins. When studied by indirect immunofluorescence on rat tissues, the serum containing anti-lamin B IgM stained smooth and striated muscles in addition to nuclear envelopes. Lamin B antibodies affinity purified from this serum were able to label muscle cells, suggesting that lamin B shares an epitope(s) with an unidentified muscular component(s). Since in an enzyme-linked immunosorbent assay there was no reactivity with a panel of proteins which are frequent targets of "natural" antibodies, these monoclonal IgM appear to belong to the rare category of IgM that possess a restricted specificity.
Assuntos
Anticorpos Monoclonais/imunologia , Imunoglobulina M/imunologia , Membrana Nuclear/imunologia , Proteínas Nucleares/imunologia , Animais , Anticorpos Antinucleares/imunologia , Especificidade de Anticorpos , Imunofluorescência , Humanos , Immunoblotting , Imunoglobulina M/isolamento & purificação , Cadeias lambda de Imunoglobulina/imunologia , Lamina Tipo B , Laminas , Músculos/imunologia , RatosRESUMO
CNS lesions were studied in polyneuropathy associated with IgM monoclonal gammopathy. Eleven out of 12 patients with IgM MGUS and one patient with Waldenstrom's disease had clinical and electrophysiological features indicating a demyelinating polyneuropathy. MRI showed CNS white matter lesions in two cases. Antibodies reacting against glycolipids present in CNS white matter were present in five cases, two of which had abnormal MRI. Central conduction times cortex-C7, obtained by magnetic stimulation, were prolonged in 3/8 patients, of which two patients had anti-CNS glycolipid antibodies.
Assuntos
Doenças do Sistema Nervoso Central/fisiopatologia , Doenças Desmielinizantes/fisiopatologia , Imunoglobulina M , Paraproteinemias/fisiopatologia , Idoso , Complexo Antígeno-Anticorpo , Doenças do Sistema Nervoso Central/diagnóstico , Doenças Desmielinizantes/diagnóstico , Feminino , Humanos , Técnicas Imunoenzimáticas , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Paraproteinemias/diagnóstico , Projetos de Pesquisa , Macroglobulinemia de Waldenstrom/diagnóstico , Macroglobulinemia de Waldenstrom/fisiopatologiaAssuntos
Anticorpos Antifosfolipídeos/sangue , Lúpus Eritematoso Sistêmico/imunologia , Adolescente , Anticorpos Anticardiolipina/sangue , Anticorpos Antifosfolipídeos/classificação , Criança , Pré-Escolar , Feminino , Humanos , Imunoglobulina G/sangue , Imunoglobulina M/sangue , Inibidor de Coagulação do Lúpus/sangue , Lúpus Eritematoso Sistêmico/genética , Masculino , Linhagem , Fosfatidiletanolaminas/imunologiaRESUMO
Anti-lamin-B autoantibodies at a significant level had been found on two occasions in the serum of a 56-year-old woman who was suffering from an apparently idiopathic chronic cold urticaria. Anti-lamin autoantibodies can be detected in various autoimmune disorders including hepatitis, vasculitis and peripheral blood cytopenia. In our patient, there was no other clinical or biological abnormality. A chance association cannot be ruled out.
Assuntos
Autoanticorpos/sangue , Temperatura Baixa/efeitos adversos , Proteínas Nucleares/imunologia , Urticária/imunologia , Feminino , Humanos , Laminas , Pessoa de Meia-Idade , Proteínas Nucleares/sangue , Pele/imunologia , Urticária/etiologiaRESUMO
Autoantibodies reactive with nuclear envelope proteins are mainly detected in human sera from patients with liver diseases. Some of these antibodies are directed to lamin B, lamins A and C, or to the lamin B receptor (LBR). We show here that the latter one are anti-idiotypic to certain anti-lamin B antibodies. Using an enzyme-linked immunosorbent assay specific for lamins we found that serum M containing anti-LBR antibodies inhibited the binding to lamins of anti-lamin B autoantibodies from three of five sera tested. Similar results were obtained using patient's M purified IgG. The binding of monoclonal IgM, lambda anti-lamin B antibodies produced by a lymphoblastoid cell line derived from the patient's blood lymphocytes was also inhibited. Absorption of serum M with nuclei abolished the inhibitory activity. No inhibition was recorded with normal sera or sera containing other antinuclear specificities. Anti-LBR antibodies did not alter the binding to lamins of sera containing anti-lamins A and C antibodies. Altogether these findings demonstrate that anti-LBR antibodies are also combining site related anti-idiotypic antibodies (Ab2) to certain anti-lamin B antibodies, provide further evidence for discrete specificities among anti-lamin B antibodies and suggest that the occurrence of autoantibodies to nuclear envelope antigens may be under idiotypic regulation.
Assuntos
Anticorpos Anti-Idiotípicos/imunologia , Autoanticorpos/imunologia , Proteínas Nucleares/imunologia , Receptores de Superfície Celular/imunologia , Receptores Citoplasmáticos e Nucleares , Animais , Autoanticorpos/análise , Humanos , Lamina Tipo B , Laminas , Cirrose Hepática Biliar/imunologia , Membrana Nuclear/imunologia , Ratos , Receptor de Lamina BRESUMO
Striking variations of serum immunoglobulin class and IgG subclass levels were observed in five patients with common variable immunodeficiency. They occurred mainly in untreated patients or, in those patients who received substitutive therapy, could not be merely due to replacement. They result in major changes in the immunoglobulin deficiency patterns, such as a shift from profound hypoimmunoglobulinaemia to IgA/IgG2/IgG4 deficiency or to isolated IgG2 deficiency. These findings have practical implications for the diagnosis and management of patients with primary humoral immunodeficiency.
Assuntos
Disgamaglobulinemia/sangue , Deficiência de IgG , Imunoglobulinas/metabolismo , Adulto , Disgamaglobulinemia/terapia , Feminino , Humanos , Deficiência de IgA , Imunoglobulina G/classificação , Imunoglobulina G/uso terapêutico , Imunoglobulina M/deficiência , Masculino , Pessoa de Meia-IdadeRESUMO
We have characterized a new antibody specificity in a panel of sera from dogs developing systemic lupus erythematosus (SLE) or clinically related autoimmune disorders. This antibody stains in a speckled fashion the nucleus of cells of different mammalian origins. The target antigen is a basic (pI 9.2) nuclear polypeptide with an apparent molecular weight of 43 kDa (p43) which is detected in various mammalian cell nuclei. p43, as studied in HeLa cells, appears to be cell cycle-independent. It is released from nuclei by salts (0.5 M NaCl or 0.25 M ammonium sulfate). Upon subfractionation of nuclear components, p43 is found in the fraction containing HnRNPs and is recovered in immunoprecipitates obtained with 4F4 monoclonal antibody to HnRNP C proteins. Immunoelectron microscopy revealed that p43 is concentrated over the dense chromatin periphery and interchromatin granule clusters. Another important feature of p43 is its ability to specifically bind wheat germ agglutinin lectin but not concanavalin A nor Ulex europaeus I, supporting the notion that p43 is a glycoprotein bearing an N-acetyl-glucosamine moiety. Consistent with this result, a radio-active p43 band is specifically immunoprecipitated by canine anti-p43 autoantibodies from HeLa cells metabolically labeled with [14C]glucosamine. Finally, anti-p43 antibodies do not immunoprecipitate SnRNA, indicating that p43 has no apparent association with SnRNPs.
Assuntos
Anticorpos Antinucleares/imunologia , Doenças do Cão/imunologia , Glicoproteínas/imunologia , Lúpus Eritematoso Sistêmico/veterinária , Proteínas Nucleares/imunologia , Ribonucleoproteínas/imunologia , Animais , Especificidade de Anticorpos , Fracionamento Celular , Cães , Células HeLa , Humanos , Técnicas Imunológicas , Lúpus Eritematoso Sistêmico/imunologia , Peso Molecular , RNA Nuclear Heterogêneo/imunologiaRESUMO
Antinuclear antibodies giving a perinuclear fluorescence and directed to a 200-kilodalton polypeptide of the nuclear envelope have been described in primary biliary cirrhosis. The purpose of this study, based on a series of 150 patients with primary biliary cirrhosis, was to ascertain the prevalence of these antibodies and to compare patients with and without these antibodies. Antinuclear antibodies giving a perinuclear fluorescence were demonstrated in 43 of the 150 patients (29%); antibodies directed to the 200-kilodalton polypeptide of the nuclear envelope were found in 40 of these 43 patients. Asthenia, arthralgia, associated extrahepatic diseases, Raynaud's phenomenon, and other antinuclear specificities were significantly less common, and titers of antimitochondrial antibodies were significantly lower in patients with antibodies directed to the 200-kilodalton polypeptide of the nuclear envelope than in patients without these antibodies. Clinical outcome, liver tests, and histological lesions did not significantly differ in patients with and without these antibodies.
Assuntos
Anticorpos Antinucleares/isolamento & purificação , Cirrose Hepática Biliar/imunologia , Membrana Nuclear/imunologia , Especificidade de Anticorpos , DNA/imunologia , Feminino , Imunofluorescência , Humanos , Immunoblotting , Masculino , Pessoa de Meia-IdadeRESUMO
The presence of autoantibodies reacting with lamins A and C was demonstrated in sera from 2 patients with rheumatoid arthritis (RA). One patient developed antilamin antibodies several years after being diagnosed as having RA; she was also found to have chronic active hepatitis. The second patient had severe nodular RA. We describe the other serologic findings in these 2 patients and discuss the relationships between antilamin antibodies and RA.